Form D · Other Health Care
NotalVision, Inc.
Manassas, VA · CIK 0001868887
Offering snapshot reported Jun 25, 2021 · SEC filing
- Reported sold
- $16.4M Offering amount: $62.5M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2021 | Initial | $16,354,874 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-404264
Source: Form D, filed Jun 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Barak Azmon | Director |
| John Hall | Executive |
| Guy Katsav | Director |
| Eliot Lazar, Md | Director |
| Anat Loewenstein | Director |
| Kester Nahen | Director, Executive |
| Quinton Oswald | Director |
| Zvika Slovin | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7717 Coppermine Drive
Manassas, VA, 20109
Manassas, VA, 20109